Key result
Bioprosthetic AVR restores normal valve function at 6 months in critical unicuspid aortic stenosis.
Why the study?
Unicuspid aortic valve is a rare congenital anomaly whose association with aortopathy and atrial septal defect is uncommon and has relevant implications for clinical and surgical management.
Case Report (n=1)
No
This case highlights the crucial role of three-dimensional transesophageal echocardiography in diagnosing a rare combination of unicommissural unicuspid aortic valve, ascending aortopathy, and ostium secundum atrial septal defect in a young adult, guiding surgical management.
Answers are grounded in this paper and cite their sources.
Supports feasibility of AVR in young unicuspid aortic valve patients; leaves open durability and aortopathy management questions.
Unicuspid aortic valve (UAV) is a rare congenital anomaly, frequently associated with early progression to severe aortic stenosis and aortopathy. We report the case of a 38-year-old woman who presented with difficult-to-control hypertension and progressive exertional dyspnea. Transthoracic echocardiography revealed critical aortic stenosis (peak gradient of 183 mmHg, mean gradient of 125 mmHg, and valve area of 0.59 cm2), associated with mild aortic regurgitation and ascending aortic dilation (45–46 mm). Three-dimensional transesophageal echocardiography confirmed a unicommissural UAV, as well as an ostium secundum atrial septal defect with a left-to-right shunt (Qp/Qs = 2.3). Given the significant hemodynamic impact, aortic valve replacement with a bioprosthetic valve was performed. The patient developed a conduction disturbance during the postoperative period, requiring permanent pacemaker implantation. At the 6-month follow-up, she was asymptomatic, and the prosthetic valve was functioning normally. This case illustrates the importance of advanced echocardiography in identifying rare valvular anomalies and highlights the uncommon association between UAV, aortopathy, and atrial septal defect in a young woman, with relevant implications for clinical and surgical management.
No takes yet. Share an insight, caveat, or question.
Santos et al. (2026) conducted a case report in Unicuspid aortic valve with critical aortic stenosis, ascending aortic dilation, and ostium secundum atrial septal defect (n=1). Bioprosthetic aortic valve replacement was evaluated on Clinical status and prosthetic valve function at 6-month follow-up. Bioprosthetic aortic valve replacement in a 38-year-old woman with unicuspid aortic valve and critical stenosis (AVA 0.59 cm²) resulted in asymptomatic status and normal valve function at 6 months.
Synapse has enriched 10 related papers. Consider them for comparative context: